LIS Technologies Inc. Appoints Subject Matter Expert John Olvera as its Integrated Safety Analysis Manager

Oak Ridge, Tennessee, Aug. 22, 2025 (GLOBE NEWSWIRE) — LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, today announced that John Olvera has been appointed as its Integrated Safety Analysis Manager. “I'm very pleased with this opportunity to work […]

LIS Technologies Inc. Appoints Subject Matter Expert John Olvera as its Integrated Safety Analysis Manager

LIS Technologies Inc. Appoints Subject Matter Expert John Olvera as its Integrated Safety Analysis Manager GlobeNewswire August 22, 2025 Oak Ridge, Tennessee, Aug. 22, 2025 (GLOBE NEWSWIRE) — LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, today announced that

Kirby McInerney LLP Announces Investigation Against Lantheus Holdings, Inc. on Behalf of Investors

(NasdaqGM:LNTH), NEW YORK, Aug. 22, 2025 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP is investigating potential claims against Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH). The investigation concerns whether Lantheus and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [LEARN MORE

Kirby McInerney LLP Announces Investigation Against Lantheus Holdings, Inc. on Behalf of Investors

Kirby McInerney LLP Announces Investigation Against Lantheus Holdings, Inc. on Behalf of Investors GlobeNewswire August 22, 2025 NEW YORK, Aug. 22, 2025 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP is investigating potential claims against Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH). The investigation concerns whether Lantheus and/or certain of its

Grupo Aeroportuario del Pacifico Announces Issuance of Bond Certificates in Mexico for Ps. 8.5 Billion

(NYSE:PAC),(BMV:GAPB.MX), GUADALAJARA, Mexico, Aug. 22, 2025 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacifico, S.A.B. de C.V., (NYSE:PAC; BMV: GAP) (“the Company” or “GAP”) announces that today completed successfully the issuance of 85 million long-term bond certificates in Mexico (Certificados Bursatiles) for a total amount of Ps. 8.5 billion (EIGHT POINT FIVE BILLION PESOS 00/100 M.N.).

Grupo Aeroportuario del Pacifico Announces Issuance of Bond Certificates in Mexico for Ps. 8.5 Billion

Grupo Aeroportuario del Pacifico Announces Issuance of Bond Certificates in Mexico for Ps. 8.5 Billion GlobeNewswire August 22, 2025 GUADALAJARA, Mexico, Aug. 22, 2025 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacifico, S.A.B. de C.V., (NYSE:PAC; BMV: GAP) (“the Company” or “GAP”) announces that today completed successfully the issuance of 85 million long-term bond certificates in

Levi & Korsinsky Helps Shareholders SueWallSt After Biohaven Ltd. Stock Drops

NEW YORK, NY / ACCESS Newswire / August 22, 2025 / – SueWallSt: Class Action Filed Against Biohaven Ltd. – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between March 24, 2023 and May 14, 2025. If you suffered

Celularity Receives Nasdaq Notice Regarding Form 10-Q

(NASDAQ:CELU),(NASDAQ:CELUW), FLORHAM PARK, N.J., Aug. 22, 2025 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company focused on addressing age-related and degenerative diseases, today announced that on August 21, 2025, Nasdaq notified the Company that it did not timely file its Quarterly Report on Form 10-Q for

Celularity Receives Nasdaq Notice Regarding Form 10-Q

Celularity Receives Nasdaq Notice Regarding Form 10-Q GlobeNewswire August 22, 2025 FLORHAM PARK, N.J., Aug. 22, 2025 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company focused on addressing age-related and degenerative diseases, today announced that on August 21, 2025, Nasdaq notified the Company that it did

Scroll to Top